Tirzepatide 15mg
Tirzepatide 15mg high-therapeutic research vial — extended-phase research dose for maximal incretin-pathway stimulation models.
Latest Batch Verified
Lot BSL032026 · Tested Mar 15, 2026HPLC purity, identity (MS), endotoxin, heavy metals — all specs passed. Spec table + per-test methodology available on the public COA page.
View Full COA Test ReportConsulta por Atacado
10+ frascos · OEM / Marca Própria · Envio em Cadeia de Frio
Orçamento de Fábrica no WhatsAppPreços por Volume
Descontos aplicados via orçamento no WhatsApp para consultas qualificadas de pesquisa / clínicas.
Tirzepatide 15mg is the most frequently cited high-therapeutic dose in published incretin research, corresponding to the upper protocol strength used in metabolic and dose-response studies. Each vial is supplied as ≥99% HPLC + MS verified lyophilized peptide with cold-chain handling from facility to laboratory.
Key Benefits
- Most-cited high-therapeutic research dose
- ≥99% HPLC + MS verified purity
- Dual GIP/GLP-1 receptor agonist
- Suitable for extended-phase protocols (weeks 12+)
- Batch-matched COA with full chain-of-custody
- Cold-chain export shipping available
Scientific Background
In published clinical-research literature, 15mg represents the highest standard dose for tirzepatide trials. At this concentration, dual GIP/GLP-1 receptor stimulation approaches maximal effect in research models, making it the reference strength for documenting peak metabolic-pathway response.
Educational Display Only
This product information is for educational purposes. Always consult licensed healthcare providers for personalized medical advice.
Frequently Asked Questions
Related Products
NAD+
Cellular health supplement supporting NAD+ levels, a crucial coenzyme involved in energy metabolism and cellular repair processes.
Available: 100mg, 200mg, 500mg
Semaglutide
GLP-1 receptor agonist for metabolic health optimization, supporting healthy weight management and glucose metabolism.
Available: 0.25mg, 0.5mg, 1mg
Tirzepatide
Dual GIP/GLP-1 receptor agonist representing the next generation of metabolic health therapeutics.
Available: 2.5mg, 5mg, 7.5mg, 15mg, 20mg, 30mg